Transgene Biotek Limited engages in the development of bio generic drugs, drug delivery systems, and pharmaceutical products in India. The company’s bio generic products comprise Orlistat, a lipase inhibitor used for obesity management; Tacrolimus, an immuno-suppressant drug used in organ transplants to prevent the rejection by the recipient body's immunological system, as well as used as a topical preparation in the treatment of severe atopic dermatitis and in cases of resistant psoriasis; and Pegylated Erythropoietin, a hormone used in renal diseases resulting in anemia and in cancer conditions. Its novel drug delivery systems include oral delivery of insulin and oral delivery of hepatitis B vaccine. The company also focuses on the development of HIV therapeutic vaccines and drugs for multiple sclerosis, as well as drugs for liver cancer, breast cancer, colon cancer, and multiple myeloma. In addition, it provides contract research and development services for pharmaceuticals; and pre-clinical and clinical research services for bio-pharmaceuticals. Further, the company offers technology outsourcing services and diagnostic services, as well as produces tissue culture plants. Transgene Biotek Limited was founded in 1991 and is based in Medak, India.

Key Statistics